Response to: ‘Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered’
Academic Article
Publication Date:
2024
Iris type:
1.1 Articolo in rivista
Keywords:
Epinephrine; Fatal anaphylaxis; Food allergy; Oral immunotherapy
List of contributors:
Novembre, E.; Gelsomino, M.; Liotti, L.; Barni, S.; Mori, F.; Giovannini, M.; Mastrorilli, C.; Pecoraro, L.; Saretta, F.; Castagnoli, R.; Arasi, S.; Caminiti, L.; Klain, A.; del Giudice, M. M.
Published in: